Dr. Mark Pegram holds the Suzy Yuan-Huey Hung Endowed Professorship in Medical Oncology at Stanford University School of Medicine. He is the Associate Director of Clinical Research at Stanford Comprehensive Cancer Institute, the Associate Dean for Clinical Research Quality, and the Medical Director of the Stanford Clinical Translational Research Unit, specializing in early-phase clinical trials. Dr. Pegram earned his medical degree from the University of North Carolina at Chapel Hill, followed by residency at UT Southwestern and fellowship at UCLA. His research centers on HER2-positive metastatic breast cancer and the development of novel therapies. He is also a leader in advancing biosimilars in oncology and has authored over 110 publications in oncology, hematology, and biosimilars.
Dr. Harit K. Chaturvedi is the Chairperson of Max Institute of Cancer Care, where he has led the development of one of India’s leading oncology programs since 2009. He introduced the Disease Management Group (DMG) model, driving specialization, clinical excellence, and academic growth across a team of over 100 oncologists.
A respected surgical oncologist, mentor, and educator, Dr. Chaturvedi has performed live surgeries, presented at global conferences, and published extensively. He has served as President of both the Indian Society of Oncology and the Indian Association of Surgical Oncology, and was the founding organizing secretary of the Indian Cancer Congress.
Prof. Dr. Somashekhar S. P. is one of India’s leading experts in surgical oncology, robotic surgery, HIPEC, and PIPAC, currently serving as Chairman of the Medical Advisory Board and Global Director of Aster International Institute of Oncology. He completed his MBBS from Mysore University, MS in General Surgery from NHL Medical College, and MCh in Surgical Oncology from GCRI, followed by advanced fellowships in robotic surgery (Roswell Cancer Center, USA), gynecologic oncology (Mayo Clinic, USA), liver surgery (Paul Brousse Hospital, Paris), thoracic oncology (Shanghai Chest Institute), and breast oncoplasty (IEO, Italy and UPMC, USA). With over 3,000 complex robotic surgeries and 1,000+ HIPEC procedures—the largest in Asia—he pioneered sentinel lymph node biopsy in India and has over 300 publications and multiple textbooks to his credit. He is a Fellow of the Royal College of Surgeons (Edinburgh), a respected teacher and university examiner for MCh and DrNB programs, and a recipient of numerous honors, including the Dr. D. D. Patel Gold Medal, Dronacharya Award, and Times Excellence Award.
